Exchange: NASDAQ·Updated 07:41 PM EST

MDXG News

News
all
press releases
MiMedx Group Bets on Surgery Growth and Sanara Deal as Wound Care Struggles
MiMedx Group (NASDAQ:MDXG) is counting on growth in its surgical business and its pending acquisition of Sanara MedTech to help offset a difficult year for its wound care franchise, Chief Financial Officer Doug Rice said at the Canaccord Genuity MedTech and Diagnostics Conference. Rice said the reg...
MarketBeat
MiMedx Group Bets on Surgery Growth and Sanara Deal as Wound Care Struggles
MiMedx Group (NASDAQ:MDXG) is counting on growth in its surgical business and its pending acquisition of Sanara MedTech to help offset a difficult year for its wound care franchise, Chief Financial Officer Doug Rice said at the Canaccord Genuity MedTech and Diagnostics Conference. Rice said the reg...
MarketBeat
More News
The Federal Trade Commission issued a Second Request on Friday, seeking additional documents and information from both companies for the merger.
Stocktwits
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts PR Newswire TAMPA, Fla., June 2, 2026 Issued on behalf of Conexeu Sciences Inc.A newly listed...
PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx...
PR Newswire
Investors need to pay close attention to MDXG stock based on the movements in the options market lately.
Zacks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx...
PR Newswire
Wall Street Zen lowered MiMedx Group from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat
MiMedx Group (NASDAQ:MDXG) Shares Up 7% - Should You Buy...
MarketBeat
Citizens Jmp dropped their price objective on MiMedx Group from $7.00 to $6.00 and set a "market outperform" rating on the stock in a report on Thursday...
MarketBeat
MiMedx Group (NASDAQ:MDXG - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by...
MarketBeat

Advertisement|Remove ads.